StockData
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc. (DFTX) income statement

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$29.38−0.78 (-2.59%)

Close on Nov 17, 2026Market cap $3.95BP/E –Yield –

Definium Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-64.1%

Financial strength

Current ratio
6.95
Debt to equity
0.04
Debt to assets
3.3%
Cash to current liabilities
416.8%

Valuation

P/E ratio
–
Price to sales
–
Price to book
4.30
Dividend yield
–

See a number that looks wrong?